AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
0.00
+0.0300 (0.70%)
May 5, 2026, 9:43 AM EDT - Market open

AVITA Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Jun '21
Net Income
-48.59-61.85-35.38-26.67-26.58
Operating Cash Flow
-48.59-61.85-35.38-26.67-26.58
Net Cash Flow
-48.59-61.85-35.38-26.67-26.58
Free Cash Flow
-48.59-61.85-35.38-26.67-26.58
FCF Margin
-67.85%-96.26%-70.56%-77.47%-90.94%
Free Cash Flow Per Share
-34.88-47.79-27.93-21.33-23.45
Levered Free Cash Flow
-48.59-61.85-35.38-26.67-26.58
Unlevered Free Cash Flow
-42.54-56.64-42.73-27.54-26.58
Updated Feb 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q